Danaher Corporation (DHR) – What Are Researchers Thinking About This Stock?

Shares of Danaher Corporation (NYSE:DHR) have earned a consensus recommendation of “Moderate Buy” from the twenty-three ratings firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $242.91.

Several equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Monday, October 26th. Robert W. Baird lifted their price target on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Royal Bank Of Canada increased their target price on shares of Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Finally, DZ Bank downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 27th.

Insider Buying and Selling

In related news, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction that occurred on Wednesday, October 28th. The shares were sold at an average price of $234.56, for a total value of $1,782,186.88. Following the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Gregory Milosevich sold 2,100 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the transaction, the executive vice president owned 22,367 shares in the company, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 10.80% of the company’s stock.

Institutional Investors Weigh In On Danaher

Institutional investors have recently made changes to their positions in the stock. Private Advisor Group LLC raised its holdings in shares of Danaher by 110.7% during the 3rd quarter. Private Advisor Group LLC now owns 34,773 shares of the conglomerate’s stock valued at $7,704,000 after buying an additional 18,266 shares in the last quarter. Hartford Funds Management Co LLC purchased a new position in shares of Danaher during the third quarter worth approximately $1,002,000. Focus Advisor Solutions LLC raised its stake in shares of Danaher by 14.8% during the third quarter. Focus Advisor Solutions LLC now owns 15,415 shares of the conglomerate’s stock worth $3,415,000 after acquiring an additional 1,985 shares in the last quarter. Checchi Capital Advisers LLC lifted its holdings in shares of Danaher by 10.3% in the 3rd quarter. Checchi Capital Advisers LLC now owns 4,670 shares of the conglomerate’s stock worth $1,035,000 after acquiring an additional 436 shares during the last quarter. Finally, Independent Advisor Alliance lifted its holdings in shares of Danaher by 7.7% in the 3rd quarter. Independent Advisor Alliance now owns 6,864 shares of the conglomerate’s stock worth $1,559,000 after acquiring an additional 488 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.6%

Shares of DHR opened at $236.41 on Wednesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The stock has a market capitalization of $166.32 billion, a price-to-earnings ratio of 38.69, a PEG ratio of 2.95 and a beta of 0.76. Danaher has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a fifty day moving average of $221.10 and a 200-day moving average of $201.55.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, topping analysts’ consensus estimates of $1.92 by $0.19. The company had revenue of $6.55 billion for the quarter, compared to analyst estimates of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. Danaher’s revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.89 earnings per share. As a group, sell-side analysts anticipate that Danaher will post 8.59 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. Danaher’s dividend payout ratio (DPR) is presently 26.19%.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.